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ABSTRACT 
The thesis entitled “Total synthesis of (+)-antimycin A3b, (+)-blastmycinone, 
cruentaren B and synthetic studies of penifulvin D” consists of three chapters. 
CHAPTER-I: Describes the total synthesis of (+)-antimycin A3b and (+)-blastmycinone. 
CHAPTER-II: Describes the total synthesis of cruentaren B. 
CHAPTER-III: Describes the synthetic studies of penifulvin D. 
 
CHAPTER-I 
Total synthesis of (+)-antimycin A3b and (+)-blastmycinone 
Antimycins belongs to a family of antifungal antibiotics, sharing a common nine-
membered dilactone ring-structure, isolated as secondary metabolites during the last 5-6 
decades from various strains of Streptomyces. The pronounced biological activities of the 
antimycins ranging from antifungal to antitumor properties make them attractive targets to 
synthetic organic chemists. Total syntheses of (+)-antimycin A3b (1) and (+)-blastmycinone 
(2) were achieved using, as a key step, a methods developed by us for the synthesis of 2-
methyl-1,3-diols via Ti(III) mediated diastereo and regeoselective opening of trisubstituted 
2,3-epoxy alcohols, to carry out the stereoselective construction of the hydroxyl acid 
segment. 
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We envisaged that the completion of 1 relied on the coupling of de-Boc dilactone 
amine 5 and acid 3 that was expected to be derived from 3-aminosalicylic acid 4 via EDCI-
HOBt coupling. The dilactone 5 would be prepared from polyketide unit 7, which in turn 
could be obtained via Cp2TiCl mediated opening of 2,3-epoxy alcohol 8. The epoxy 
alcohol 8 could be prepared from commercially available starting chiron (-)-ethyl lactate 9. 
(+)-Blastmycinone, a degradable product of antimycin, could be derived from polyketide 
unit 7 (Scheme 1). 
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We commenced our synthesis from commercially available starting material (S)-
ethyl lactate 9. PMB protection of 9 followed by DIBAL-H reduction gave 11. Horner-
Wadsworth-Emmons olefination of 11 with (EtO)2P(O)CH(n-Bu)CO2Et using Z selective 
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reagent furnished a mixture of Z and E alkenes 12. Reduction of the mixture of α,β-
unsaturated ester with DIBAL-H followed by mCPBA epoxidation gave 8. In this stage 
both the isomers were separated by silica gel column chromatography. The trisubstituted 
epoxy alcohol was then treated with Cp2TiCl to carry out crucial radical mediated epoxide 
opening reaction to give 13. Reductive opening of 13 using Na(CN)BH3-TMSCl, followed 
by silyl protection using TBSCl gave 14.  
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Compound 14 was next subjected to streocentre inversion following a two-step 
oxidation-reduction protocol to furnish the requisite isomer, which on acylation with 
isovaleryl chloride afforded 7. PMB deprotection of 7 using DDQ followed by coupling 
with Boc-Thr(Bn)-OH using DCC-DMAP gave 16. TBS deprotection followed by two-
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step oxidation of 16, using DMP and NaClO2 gave acid 17. Benzyl deprotection of 17 
using Pd(OH)2 and H2, followed by Shiine cyclization using MNBA furnished dilactone 5. 
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The aromatic acid was prepared from 3-aminosalicylic acid 4 in four steps 
following reported procedure. N-formylation of 4, followed by esterification with MeI 
gave 18. Benzylation of the phenolic hydroxyl of 18 with BnBr followed by methyl ester 
hydrolysis using LiOH-H2O afforded aromatic acid 3. 
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Boc-deprotection of 5 with TFA gave amine salt, which on coupling with 3 using 
EDCI-HOBt gave19. Compound 19 on debenzylation with Pd-C/ H2 furnished antimycin 
A3b. The 1H and 13C NMR spectra and optical rotation, [α]D25 = +75.6 (c = 0.25, CHCl3), of 
our synthetic product 1 matched with those reported for antimycin A3b by other groups. 
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The synthesis of (+)-blastmycinone, a degradation product of antimycin, was 
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achieved in six consecutive steps from 7. Desilylation of 7 using (±) CSA followed by two-
step oxidation using DMP and NaClO2, and finally treatment with CH2N2 gave ester 10. 
PMB deprotection of 10 using DDQ followed by cyclisation using (±) CSA afforded (+)-
blastmycinone. 
The 1H NMR and 13C NMR spectra and optical rotation [α]D27 = +9.1 (c = 0.17, 
CHCl3), of our synthetic product 10 matched with those reported for the natural product 
(+)-blastmycinone (literature [α]D27 = +11.2 (c = 0.85, CHCl3). 
 
CHAPTER-II 
 
Total synthesis of cruentaren B 
 
In search of new biologically active natural products, myxobacteria have been proven to be 
a rich repertoire of innumerable secondary metabolites with novel structures and wide-
ranging properties. The benzolactones, cruentaren A (1) and its ring-contracted congener 
cruentaren B (2) (Figure 1), are two such molecules isolated from myxobacterium 
Byssovorax cruenta. While cruentaren A strongly inhibited the growth of yeasts and 
filamentous fungi and showed high cytotoxicity against L929 mouse fibroblast cells, 
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cruentaren B showed only marginal cytotoxicity and no antifungal activity. However, 
thorough evaluation of the cytotoxic and other biological properties of cruentaren B has 
not been possible due to the limited natural abundance of this compound. Chemical 
synthesis, not only, remains as the only option to get larger quantities of the molecule 
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necessary for further biological studies, but can also help to design and build more potent 
synthetic analogs. Because of their novel structures and wide-ranging biological activities, 
cruentarens have attracted the attention of synthetic chemists worldwide. 
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A retrosynthetic analysis of cruentaren B (2) is shown in Scheme 1. We envisioned 
constructing the target molecule from the fragments 5-7 via an acetylide-triflate cross-
coupling reaction (6 + 7), followed by selective hydrogenation to the Z-olefin and a Wittig 
olefination with 5. The resulting product after global deprotection of the protecting groups 
and a base-catalyzed cyclization was expected to furnish the target natural product 2. 
While compound 6 could be built from 2,4,6-trihydroxybenzoic acid 11, the acetylenic 
intermediate 7 could be derived from commercially available methyl (R)-3-hydroxyl-2-
methylpropionate 14. An enantioselective aldol reaction on butyraldehyde 9 could furnish 
the ylide component 5. 
Our synthesis commenced with the construction of the benzolactone moiety 6 
(Scheme 2). Acetonide protection of 11 followed by selective O-methylation, under 
Mitsunobu conditions, gave 15. Next, the alcohol 15 was treated with Tf2O in pyridine to 
give the triflate compound which upon Pd-catalyzed Stille coupling with allylstannane 
gave the desired product 10. Dihydroxylation of 10 with N-methylmorpholine (NMO) and 
OsO4 followed by oxidative cleavage with NaIO4 gave an aldehyde, which on asymmetric 
crotylboration following Brown’s protocol and using (–)-Ipc2B(crotyl), resulted in the 
formation of an anti-adduct, the homoallylic alcohol. Silyl protection of the secondary 
hydroxyl group with TBSOTf gave 16. Compound 16 was converted to the primary 
alcohol 6 in three steps – dihydroxylation followed by oxidative cleavage and a NaBH4 
reduction. 
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Synthesis of 7 is depicted in Scheme 3. Aldehyde 18, prepared from commercially 
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available methyl (R)-3-hydroxyl-2-methylpropionate 14 in three steps by TBDPS 
protection, reduction and oxidation, was subjected to the modified Evans aldol reaction 
using propanoyl oxazolidinone 19 as a chiral auxiliary to afford aldol product 20 in good 
yield and diastereoselectivity after chromatographic purification. Silyl protection of the 
secondary hydroxyl group as TBS ether with TBSOTf followed by reductive removal of 
the chiral auxiliary gave the alcohol 13. Swern oxidation of the alcohol 13 followed by 
Mukaiyama aldol with TBS enol ether of t-butyl acetate gave the required diastereomer, 
which on sillyl protection using TBSOTf gave 12. DIBAL-H reduction of 12 gave the 
alcohol 21. Dess-Martin periodinane (DMP) oxidation of 21 gave an aldehyde, which was 
converted to the alkyne compound 22 using Corey’s protocol. Global deprotection of the 
silyl protecting groups followed by selective mono tosylation of the primary hydroxyl 
group and cyanation with NaCN in the presence of a catalytic amount of NaI gave the 
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cyano compound 23. Acetonide protection followed by DIBAL-H reduction, hydrolysis 
and finally NaBH4 reduction gave the alcohol 24. Next, deprotection of the acetonide with 
CSA and global protection of the resulting triol with TBSOTf afforded 7. 
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The synthetic route for the right hand segment 5 is depicted in Scheme 4. Non-
Evans syn-aldol reaction between 25 and butanal 9 using Crimmins’ protocol gave 
secondary alcohol 26. Protection of the hydroxyl group as TBS ether, followed by 
oxidative removal of the chiral auxiliary with H2O2 and LiOH gave 8. Compound 8 was 
coupled with 2-aminoethanol using common amide bond forming protocol with EDCI and 
HOBt to afford 27. Wittig salt 5 was generated in two steps with conversion of the 
hydroxyl group to an iodo, followed by the reaction of the iodide with Ph3P. 
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With all the three segments 5-7 in hand, we undertook studies to stitch them 
together to build the entire framework of the cruentaren B (Scheme 5). The triflate, 
generated from 6 using Tf2O, was treated with lithiated alkyne moiety of 7 to afford the 
desired coupling product 28. After successful 1st coupling, we deprotected the primary 
TBS selectively with HF-py complex to give an intermediate alcohol, which was reduced 
by hydrogenation using Pd-BaSO4/quinoline to give the Z-olefin 4. Next, Dess-Martin 
periodinane (DMP) oxidation followed by a selective Z-olefination furnished the entire 
carbon frame work 29 of the target molecule. Reaction between the ylide, generated from 
5, and aldehyde at –80 °C in THF-HMPA gave the required Z-olefin. The Product 29 was 
subjected to global deprotection of the TBS groups to afford the desilylated product, which 
on treatment with LiOH.H2O in THF afforded the target molecule, cruentaren B (2) 
(Scheme 5). The spectral data and optical rotation data were virtually identical to those of 
the natural product. 
 
CHAPTER III 
Synthetic studies of penifulvin D 
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P. griseofulvum, world wide in its distribution, shows significant insecticidal 
activity in assays against the fall armywarm. An organic extract from cultures of P. 
griseofulvum NRRL35584 showed potent antifungal and antiinsectan activity in 
preliminary assay. Studies of this extract have lead to the discovery of novel antiinsectan 
sesquiterpenoid penifulvin D (1). The overall structure of penifulvin D assigned by 
analysis of NMR data, having dioxa[5.5.5.6]fenestrance ring system in which four rings 
share a central quaternary carbon. Additionally there are two more quaternary carbons, a γ- 
and δ- lactone sharing the acylal center and a total of five streogenic centre congested on a 
15 carbon. 
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Retro synthetic analysis of penifulvin D (1) is illustrated in Scheme1. We 
envisaged that completion of 1 relied on oxidation of 2 which was expected to be derived 
from 3 via cyanohydrin formation, followed by functional groups interconversions. 
Alcohol 4 could be prepared from 5 via Cp2TiCl mediated radical cyclisation. Ester 5 
could be obtained from 6 by two carbon olefination and functional groups 
interconversions. The keto alcohol 6 could be derived from commercially available 
cyclopentanone 7 by using Michael addition followed by, one carbon olefination, allylic 
oxidation and functional group interconversion. 
 
We commenced our synthesis from commercially available starting material 
cyclopentanone 7. According to our retro synthetic strategy, first step involved crucial 
Michael addition reaction. To carry out the Michael addition reaction, cyclopentanone 7 
was converted to the corresponding TMS enol ether derivative 8. Compound 8, without 
further purification and characterization, was taken forward for the Michael addition 
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reaction with mesityl oxide to give 9.  
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Selective protection of one of the carbonyl groups of 9 with 1,3-
propanedithiobis(trimethylsilane) afforded 10. Compound 10 on one carbon olefination 
followed by allylic oxidation with SeO2 gave 11. Treatment of 11 with AgNO3, followed 
by reaction with lithiated ethyl ethynyl ether and finally Mayer-Schuster rearrangement 
furnished the α,β-unsaturated ester 12. mCPBA epoxidation followed by radical cyclisation 
using Cp2TiCl afforded 13. The relative stereochemistry of the newly generated centre was 
confirmed by NOESY experiment. Although we have not get the desired streocentre, we 
still proceed to construct the frame work of penifulvin D. Silyl protection of 13 using 
TBSCl, followed by oxidation with DMP gave 14 (Scheme 2) . The treatment of 14 with 
TMSCN and ZnI2 in CH2Cl2 gave an unidentified compound. Many other methods for the 
formation of cyanohydrin were unsuccessful, leaving the total synthesis of the molecule 
still elusive. 
 
 
 
 
 
